Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation Combined With Tafasitamab, Lenalidomide, and Standard Immunochemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma

The First Affiliated Hospital of Soochow University · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
relapsed/refractory diffuse large b cell lymphoma, tafasitamab, lenalidomide, relapsed/refractory diffuse large b-cell lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 842521
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.